Kadmon Initiates Phase 2 Clinical Trial Evaluating KD025 in Chronic Graft-Versus Host Disease
Yahoo! Finance USA,
NEW YORK--(BUSINESS WIRE)-- Kadmon Holdings, Inc. ( KDMN ) today announced that the first patient has been dosed in a Phase 2…
NEW YORK--(BUSINESS WIRE)-- Kadmon Holdings, Inc. ( KDMN ) today announced that the first patient has been dosed in a Phase 2…
NEW YORK — (BUSINESS WIRE) — Kadmon Holdings, Inc. (NYSE:KDMN) today announced that the first patient has been dosed in a Phase…
NEW YORK--( BUSINESS WIRE )--Kadmon Holdings, Inc. (NYSE:KDMN) today announced that the first patient has been dosed in a double…
NEW YORK--(BUSINESS WIRE)-- Kadmon Holdings, Inc. (NYSE: KDMN ) today announced that the first patient has been dosed in a…